Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.34 |
| ▸ | SCN9A | Q15858 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13225194 | 0.91 | ALDH1A1 (0.43) | ALDH1A1L3MBTL1 | |
| SCHEMBL13225421 | 0.87 | ALDH1A1 (0.34) | ALDH1A1L3MBTL1 | |
| SCHEMBL13225507 | 0.87 | MAPT (0.42) | ALDH1A1L3MBTL1HCRTR2 | |
| SCHEMBL10099514 | 0.84 | ALDH1A1 (0.38) | ALDH1A1L3MBTL1 | |
| SCHEMBL107375 | 0.84 | ALDH1A1 (0.40) | ALDH1A1L3MBTL1 | |
| SCHEMBL686574 | 0.84 | ALDH1A1 (0.40) | ALDH1A1L3MBTL1 | |
| SCHEMBL13225282 | 0.83 | HCRTR2 (0.33) | HCRTR2SCN9A | |
| SCHEMBL13225419 | 0.83 | ALDH1A1 (0.36) | ALDH1A1L3MBTL1 | |
| SCHEMBL13225508 | 0.83 | ALDH1A1 (0.36) | ALDH1A1L3MBTL1 | |
| SCHEMBL686576 | 0.82 | CYP19A1 (0.40) | ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7786322-B2 | Salt suitable for an acid generator and a chemically amplified resist composition containing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-08-31 | — | — | US | disclosed |
| US-20070122750-A1 | Salt suitable for an acid generator and a chemically amplified resist composition containing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070122750-A1 | Salt suitable for an acid generator and a chemically amplified resist composition containing the same | HCN3, NHERF1, HCN4 | ALDH1A1 972/4885L3MBTL1 4862/4885HCRTR2 454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.